Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by HAYES, J. R.
Right arrow Articles by BORZELLECA, J. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by HAYES, J. R.
Right arrow Articles by BORZELLECA, J. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1986 Oxford University Press

research-article

Acute, 14-Day Repeated Dosing, and 90-Day Subchronic Toxicity Studies of Carbon Tetrachloride in CD-1 Mice1,2

JOHNNIE R. HAYES*, LYMAN W. CONDIE, JR.{dagger} and JOSEPH F. BORZELLECA*

*Department of Pharmacology and Toxicology, Medical College of Virginia Box 613, MCV Station, Richmond, Virginia 23298 {dagger}U.S. Environmental Protection Agency 26 West St. Clair Street, Cincinnati, Ohio 45268

Acute, 14-Day Repeated Dosing, and 90-Day Subchronic Toxicity Studies of Carbon Tetrachloride in CD-I Mice. HAYES, J.R., CONDIE, L.W., JR., AND BORZELLECA, J.F. (1986). Fundam. Appl. Toxicol. 7, 454-463. CD-I mice received carbon tetrachloride daily by gavage for 14 or 90 consecutive days. Corn oil was the vehicle used. The 14-day study involved doses of 625, 1250, and 2500 mg/kg; the 90-day subchronic study involved doses of 12, 120, 540, and 1200 mg/kg. The 14-day study revealed a dose-dependent mortality and decreased body weight in males, whereas females demonstrated mortality only at the high dose. Other dose-dependent findings included decreased fibrinogen and lymphocytes; increased LDH, SGPT (ALT), and SGOT (AST); increased liver weights and ratios in both sexes; and decreased lung, thymus, and kidney weights in males only. There were no compound-related deaths in the 90-day study. There were no consistent compound-related effects on any of the hematological or urinary parameters evaluated. LDH, SGPT (ALT), SGOT (AST), ALP, cholesterol, and bilirubin were increased in an apparent dose-dependent manner while blood glucose levels decreased at all dosage levels. Liver, spleen, and thymus weights and ratios were increased at all dosage levels in both sexes. Histopathology revealed no kidney damage, but liver damage was observed at all doses in both sexes. A no-observable-adverse-effect level was not obtained in these studies.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.